CNSX:ACG

438280 Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume2,966 shs
Average Volume6,184 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

438280 (CNSX:ACG) Vs. THCX, GLH, HC, BIO, BBM, and LOVE

Should you be buying ACG stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to 438280, including (THCX.V) (THCX), 31444 (GLH), 815446 (HC), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), and Cannara Biotech (LOVE).

438280 (CNSX:ACG) and (THCX.V) (CVE:THCX) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership and profitability.

Earnings and Valuation

This table compares 438280 and (THCX.V)'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
438280N/AN/AN/AN/AN/A
(THCX.V)N/AN/AN/AN/AN/A

Profitability

This table compares 438280 and (THCX.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
438280N/AN/AN/A
(THCX.V)N/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for 438280 and (THCX.V), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
4382800000N/A
(THCX.V)0000N/A

31444 (CNSX:GLH) and 438280 (CNSX:ACG) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk.

Profitability

This table compares 31444 and 438280's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
31444N/AN/AN/A
438280N/AN/AN/A

Valuation & Earnings

This table compares 31444 and 438280's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
31444N/AN/AN/AN/AN/A
438280N/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and price targets for 31444 and 438280, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
314440000N/A
4382800000N/A

815446 (CNSX:HC) and 438280 (CNSX:ACG) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for 815446 and 438280, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
8154460000N/A
4382800000N/A

Profitability

This table compares 815446 and 438280's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
815446N/AN/AN/A
438280N/AN/AN/A

Valuation and Earnings

This table compares 815446 and 438280's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
815446N/AN/AN/AN/AN/A
438280N/AN/AN/AN/AN/A

438280 (CNSX:ACG) and Bio-Rad Laboratories (CNSX:BIO) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability.

Profitability

This table compares 438280 and Bio-Rad Laboratories' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
438280N/AN/AN/A
Bio-Rad LaboratoriesN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for 438280 and Bio-Rad Laboratories, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
4382800000N/A
Bio-Rad Laboratories0000N/A

Earnings & Valuation

This table compares 438280 and Bio-Rad Laboratories' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
438280N/AN/AN/AN/AN/A
Bio-Rad LaboratoriesN/AN/AN/AN/AN/A

438280 (CNSX:ACG) and Blueberries Medical (CNSX:BBM) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Profitability

This table compares 438280 and Blueberries Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
438280N/AN/AN/A
Blueberries MedicalN/AN/AN/A

Valuation & Earnings

This table compares 438280 and Blueberries Medical's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
438280N/AN/AN/AN/AN/A
Blueberries MedicalN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and target prices for 438280 and Blueberries Medical, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
4382800000N/A
Blueberries Medical0000N/A

438280 (CNSX:ACG) and Cannara Biotech (CNSX:LOVE) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, dividends and profitability.

Earnings & Valuation

This table compares 438280 and Cannara Biotech's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
438280N/AN/AN/AN/AN/A
Cannara BiotechN/AN/AN/AN/AN/A

Profitability

This table compares 438280 and Cannara Biotech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
438280N/AN/AN/A
Cannara BiotechN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations for 438280 and Cannara Biotech, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
4382800000N/A
Cannara Biotech0000N/A


438280 Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
THCX
(THCX.V)
0.6$5.30flatC$0.00N/A0.00High Trading Volume
News Coverage
GLH
31444
0.4N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
HC
815446
0.5N/AN/A$0.00N/A0.00Gap Down
BIO
Bio-Rad Laboratories
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
BBM
Blueberries Medical
0.6N/AN/A$0.00N/A0.00High Trading Volume
LOVE
Cannara Biotech
0.7N/AN/A$0.00N/A0.00High Trading Volume
CALI
China Auto Logistics
1.3N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
MJ
ETFMG Alternative Harvest ETF
0.5N/AN/A$0.00N/A0.00News Coverage
Gap Down
BOSS
Global X Founder-Run Companies ETF
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
LHS
Liberty Health Sciences
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
LIB
Liberty Leaf
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Down
MMEN
Medmen Enterprises
0.6N/AN/A$0.00N/A0.00High Trading Volume
RQB
Ravenquest Biomed
0.6N/AN/A$0.00N/A0.00High Trading Volume
TGIF
SoFi Weekly Income ETF
0.6N/AN/A$0.00N/A0.00High Trading Volume
Valeant Pharmaceuticals International logo
VRX
Valeant Pharmaceuticals International
0.5N/AN/AC$0.00N/A0.00
VRT
Vertiv
0.5N/AN/A$0.00N/A0.00Gap Down
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.